# AngioDynamics Inc. (ANGO) fundamentals

Data as of 2026-09-08. NASDAQ, United States. Sector: Healthcare / Health Care Equipment & Supplies. Price $15.20, market value $628 million.

## Valuation
- **P/E (trailing): n/a** (negative earnings). AngioDynamics Inc. reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **Price / sales: 2.0×**. Each dollar of revenue is priced at 2.0×.
- **Price / book: 3.7×**. The shares trade at 3.7× book value; book value is a meaningful part of the valuation.
- **Free-cash-flow yield: 0.1%** (5-yr avg -3.6%). Free cash flow equals 0.1% of the market value, above its five-year average of -3.6%, so the shares are cheaper on cash than they have usually been.

## Profitability
- **Gross margin: 54.6%**. AngioDynamics Inc. keeps 54.6% of revenue after the direct cost of what it sells.
- **Operating margin: -12.5%**. Operating margin is negative: the business loses money before interest and tax.
- **Net margin: -11.5%**. The company reported a net loss over the last twelve months.
- **Return on equity: -21.5%**. Return on equity is negative because earnings are negative.
- **Return on invested capital: -27.0%**. Return on all capital, debt included, is -27.0%: close to or below the cost of capital, so growth may not create value.
- **Return on assets: -13.8%**. Each dollar of assets produces -13.8% of profit.

## Growth
- **Revenue growth (1 yr): 9.5%** (3-yr -1.9%/yr, 5-yr 1.9%/yr). Revenue grew 9.5% over the last year, against 1.9% a year compounded over five years: growth is accelerating.
- **EPS growth (1 yr): -6.0%**. Earnings per share fell 6.0%, slower than revenue, so margins compressed.

## Financial health
- **Debt to equity: 0.00**. Debt is 0.00 times equity: a conservative balance sheet.
- **Net debt / EBITDA: 3.2×**. It would take 3.2 years of operating earnings to repay net borrowings, above the 3× level most lenders treat as comfortable.
- **Current ratio: 2.19** (quick 2.19). Current assets cover the next year's liabilities 2.19 times.
- **Altman Z-score: 5.91**. A Z-score of 5.91 places the company in the safe zone for bankruptcy risk.
- **Piotroski F-score: 5/9**. 5 of 9 checks pass: mixed.

## Dividends
- **Dividend: none**. AngioDynamics Inc. does not currently pay a dividend.

## Price and momentum
- **Total return (1 yr): 41.7%** (YTD 18.4%, 3-mo 27.3%). The shares are up 41.7% over twelve months including dividends.
- **From 52-week high: -6.7%** (61.9% above the low). Trading 7% below its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 47**. An RSI of 47 is neutral.
- **Beta (1 yr): 0.96** (volatility 43%). Beta of 0.96 against the S&P 500: the shares move roughly with the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=ANGO · Page: https://foliofundamentals.com/stocks/ango

Not investment advice.